help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 18, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1419
A more recent version of this article appeared on March 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/3/920    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asakura, Y.
Right arrow Articles by Adachi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asakura, Y.
Right arrow Articles by Adachi, M.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology

Submitted on June 26, 2007
Accepted on December 11, 2007

Endocrine and radiological studies in patients with molecularly confirmed CHARGE syndrome

Yumi Asakura*, Yuko Toyota, Koji Muroya, Kenji Kurosawa, Kazutoshi Fujita, Noriko Aida, Hiroshi Kawame, Kenjiro Kosaki, and Masanori Adachi

Department of Endocrinology and Metabolism, Genetics and Radiology, Kanagawa Children's Medical Center, Kanagawa; Japan; Department of Genetics, Nagano Children's Hospital, Nagano; Japan; Department of Pediatrics, Keio University School of Medicine, Tokyo; Japan

* To whom correspondence should be addressed. E-mail: yumi79{at}mvb.biglobe.ne.jp.

CONTEXT: CHARGE syndrome is a complex of congenital malformations and CHD7 has been reported as a major gene involved in the etiology.

OBJECTIVE: We performed endocrine and radiological studies to determine if endocrinological disorders such as hypogonadotropic hypogonadism, growth hormone deficiency or hypothyroidism are involved, and also if olfactory bulb hypoplasia and semi-circular canals aplasia are major signs, in patients with molecularly confirmed CHARGE syndrome

DESIGN: Clinical features, endocrinological assessments and radiological abnormalities in 8 children (5 boys and 3 girls) whose molecular analyses were available were evaluated among 15 children clinically diagnosed with CHARGE syndrome at our institute.

RESULTS: We identified heterozygous CHD7 mutations in all patients screened for mutations. Four boys had micropenis and/or cryptorchidism. One was diagnosed with GH deficiency and the other was diagnosed with hypothyroidism. CT findings revealed aplasia of semi-circular canals. MRI studies of the olfactory bulb region revealed abnormal olfactory sulci and bulb development in all children.

CONCLUSION: We suggest that hypogonadism, GH deficiency and hypothyroidism could be possible endocrinological defects in patients with CHD7 mutations, and. that olfactory bulb hypoplasia as well as semi-circular canal aplasia should be considered as a major sign for CHARGE syndrome and recommend CT scan of the temporal bone and MRI study of the olfactory bulb region.


Key words: CHARGE syndrome • CHD7 • olfactory bulb • hypogonadotropic hypogonadism • growth failure • hypothyroidism • Kallmann syndrome







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society